Myriad Genetics is a leading molecular diagnostic company dedicated to making a difference in patients' lives through the discovery and commercialization of transformative tests to assess a person's risk of developing disease, guide treatment decisions and assess risk of disease progression and recurrence.
Hereditary Cancer Tests
Myriad's hereditary cancer tests provide vital information to help people with a family history of disease understand their own risk of developing the disease. With this information, they can take steps to prevent the disease, delay the onset of disease, or catch the disease at an earlier stage where outcomes are better.
Many cancers are caused by mutated genes we inherit from our parents. The discovery of genes involved in cancer allows us to test for cancer causing changes in these genes. If a person has certain genetic changes passed on from their parents, they are at a much higher risk of getting cancer than people who do not have these changes. Because of this higher risk, healthcare providers and their patients may choose to take measures to reduce their risk of developing cancer. There are effective options to help lower a patient’s risk of cancer such as more intensive screening for cancer, preventive medication and risk reducing surgeries. Once the potential risk of cancer is identified, the healthcare provider and the patient can choose the best way to delay or even possibly prevent the development of certain cancers.
Myriad’s hereditary cancer testing products have been used to help millions of people with a strong family or personal history of cancer. These families usually have cancers that occur at an earlier age (e.g. below 50), occur in several family members or occur multiple times in the same individual. These cancers can be found on either the father’s side of the family or the mother’s side. Myriad offers testing for several inherited cancers including breast, ovarian, colon, uterine and skin (melanoma) cancer. Healthcare providers and their patients use the information provided by Myriad to make better healthcare choices. This information can help improve health and quality of life while reducing healthcare costs.
To learn more about each of our Hereditary Cancer Testing products, simply click on a product below:
Myriad’s prognostic tests are designed to provide information about the level of aggressiveness of a cancer to a healthcare provider and their patient so that they can make more informed treatment decisions. This type of testing can enable the physician to better define a treatment/monitoring strategy, thereby enhancing the patient’s quality of life.
Prolaris® testing assesses the aggressiveness of a man’s prostate cancer by measuring the expression level of genes involved with cell cycle progression in tumor specimens. To learn more about Prolaris, please visit www.prolaristest.com.
Personalized Medicine products provide valuable information for a healthcare provider to customize medical management plans individually for each patient. With a treatment plan tailored to the patient’s individual characteristics, the patient has the opportunity to receive the right treatment at the right levels to improve effectiveness and avoid unwanted side effects.
Myriad’s personalized medicine products have been designed to help cancer patients and their doctors individualize treatments to achieve improved response to therapy and less toxicity. In cancer, the treatment plans usually follow standard pathways that are adjusted for patients based on the healthcare providers’ medical judgment. However, toxicity can happen because each of us is different and will have a different response to a therapy. Myriad’s products help doctors optimize chemotherapy drug treatments for each patient to help lower toxicity while improving tumor response. These breakthrough products are designed to improve a person’s cancer care and reduce healthcare costs.
To learn more about each of our predictive medicine products, simply click on a product below: